首页> 外文会议>International conference on environmental biotechnology and materials engineering;EBME 2011 >Myeloperoxidase (MPO) Gene Polymorphism confers Cirrhotic Patients with Hepatopulmonary Syndrome
【24h】

Myeloperoxidase (MPO) Gene Polymorphism confers Cirrhotic Patients with Hepatopulmonary Syndrome

机译:髓过氧化物酶(MPO)基因多态性赋予肝硬化肝肺综合征患者

获取原文

摘要

In this study,we investigated the-463G/A promoter polymorphism of the MPO gene,in an attempt to explore the role of MPO in the pathogenesis of HPS caused by cirrhosis.The polymorphism of the MPO gene means the individual genotypes have different initial mRNA transcription activities and different expression levels,which further influences the activities of enzymes and results in the variation in disease susceptibility.This paper addresses gene polymorphisms play a key role in the development of HPS in cirrhotic patients.
机译:在这项研究中,我们调查了MPO基因的-463G / A启动子多态性,以试图探索MPO在肝硬化引起的HPS发病机理中的作用。MPO基因的多态性意味着各个基因型具有不同的初始mRNA转录活性和不同的表达水平,进一步影响酶的活性,导致疾病易感性的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号